Supernus Pharmaceuticals (SUPN) Misses Q2 Earnings Estimates
SUPNSupernus Pharmaceuticals(SUPN) ZACKS·2024-08-07 07:46

Supernus Pharmaceuticals (SUPN) came out with quarterly earnings of 0.36pershare,missingtheZacksConsensusEstimateof0.36 per share, missing the Zacks Consensus Estimate of 0.37 per share. This compares to loss of 0.02pershareayearago.Thesefiguresareadjustedfornon−recurringitems.Thisquarterlyreportrepresentsanearningssurpriseof−2.700.02 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -2.70%. A quarter ago, it was expected that this drugmaker would post earnings of 0.39 per share when it actually produced break-even earnings, delivering a surprise of -100%.Over the last four quarters, the ...